Showing results (121-130 of 143) with videos related to
Sort By:
Pageof 15
International Journal of Antimicrobial Agents|July 4, 2012
Correlation between carbapenem consumption and resistance to carbapenems among Enterobacteriaceae isolates collected from patients with intra-abdominal infections at five medical centers in Taiwan, 2006-2010Cheng-Mao Ho, Mao-Wang Ho, Yung-Ching Liu, et al.International Journal of Antimicrobial Agents|July 4, 2012
In vitro susceptibilities of non-Enterobacteriaceae isolates from patients with intra-abdominal infections in the Asia-Pacific region from 2003 to 2010: results from the Study for Monitoring Antimicrobial Resistance Trends (SMART)Yuag-Meng Liu, Yao-Shen Chen, Han-Siong Toh, et al.International Journal of Antimicrobial Agents|July 4, 2012
Epidemiology and antimicrobial susceptibility profiles of Gram-negative bacteria causing urinary tract infections in the Asia-Pacific region: 2009-2010 results from the Study for Monitoring Antimicrobial Resistance Trends (SMART)Po-Liang Lu, Yung-Ching Liu, Han-Siong Toh, et al.International Journal of Antimicrobial Agents|July 4, 2012
Impact of revised CLSI breakpoints for susceptibility to third-generation cephalosporins and carbapenems among Enterobacteriaceae isolates in the Asia-Pacific region: results from the Study for Monitoring Antimicrobial Resistance Trends (SMART), 2002-2010Chi-Chang Huang, Yao-Shen Chen, Han-Siong Toh, et al.Antimicrobial Agents and Chemotherapy|June 25, 2003
Telithromycin- and fluoroquinolone-resistant Streptococcus pneumoniae in Taiwan with high prevalence of resistance to macrolides and beta-lactams: SMART program 2001 dataPo-Ren Hsueh, Lee-Jene Teng, Tsu-Lan Wu, et al.International Journal of Antimicrobial Agents|December 17, 2008
Nationwide surveillance in Taiwan of the in-vitro activity of tigecycline against clinical isolates of Gram-positive cocciShih-Ming Tsao, Hsiu-Chen Lin, Chun-Ming Lee, et al.International Journal of Antimicrobial Agents|December 17, 2008
In-vitro activity of tigecycline against clinical isolates of Acinetobacter baumannii in TaiwanJien-Wei Liu, Lih-Shinn Wang, Yu-Jen Cheng, et al.International Journal of Antimicrobial Agents|December 17, 2008
Nationwide surveillance in Taiwan of the in-vitro activity of tigecycline against clinical isolates of extended-spectrum beta-lactamase-producing EnterobacteriaceaeChin-Te Lu, Yin-Ching Chuang, Wu Sun, et al.Antimicrobial Agents and Chemotherapy|June 25, 2003
Telithromycin and quinupristin-dalfopristin resistance in clinical isolates of Streptococcus pyogenes: SMART Program 2001 DataPo-Ren Hsueh, Lee-Jene Teng, Chun-Ming Lee, et al.International Journal of Antimicrobial Agents|December 17, 2008
In-vitro activity of tigecycline against clinical isolates of Acinetobacter baumannii in Taiwan determined by the broth microdilution and disk diffusion methodsChun-Hsing Liao, Hsiang-Chi Kung, Gwo-Jong Hsu, et al.Pageof 15